arrow
Back
M

Milton Packer

Baylor Scott and White Health

139H-index
898Paper Count
11.8WCitation Count
Published Papers 448
Publication Date
Optimal serum potassium concentrations in heart failure: an individual patient data meta-analysis
err2026-05-28
err0
PREAI
errRyohei Ono; Misato Chimura; Kieran F Docherty; Alasdair D Henderson; Ross Campbell; Akshay S Desai; Michel Komajda; Milton Packer; Marc A Pfeffer; Bertram Pitt; John R Teerlink; Faiez Zannad; Muthiah Vaduganathan; Orly Vardeny; Mingming Yang; Pardeep S Jhund; Scott D Solomon; John J V McMurray
errShare
errSave
Obesity, aldosterone, and natriuretic peptides in patients with heart failure and reduced ejection fraction
err2025-12-01
err0
errOAAI
errMatsumoto, Shingo; Butt, Jawad H.; Docherty, Kieran F.; Jhund, Pardeep S.; Abraham, William T.; Desai, Akshay S.; Kober, Lars; Rouleau, Jean L.; Packer, Milton; Vaduganathan, Muthiah; Solomon, Scott D.; McMurray, John J., V
errShare
errSave
Reply
errJACC
IF0
err2025-11-12
err0
PREAI
errBarry A. Borlaug; Michael R. Zile; Christopher M. Kramer; Milton Packer
errShare
errSave
Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular–kidney–metabolic conditions: A pooled analysis of randomised trials
err2025-11-10
err0
errOAAI
errJoão Pedro Ferreira PhD; Pedro Marques MD; Stefan D. Anker PhD; Javed Butler MD; Gerasimos Filippatos PhD; Abhinav Sharma PhD; Francisco Vasques-Nóvoa MD; Luís Mendonça PhD; João Sérgio Neves PhD; Milton Packer MD; Faiez Zannad PhD
errShare
errSave
Serum Magnesium and the Effect of Empagliflozin in Heart Failure With Reduced Ejection Fraction
err2025-10-31
err0
PREAI
errJoão Pedro Ferreira; Stefan D. Anker; Javed Butler; Francisco Vasques-Nóvoa; Pedro Marques; Stuart Pocock; Gerasimos Filippatos; Faiez Zannad; Milton Packer
errShare
errSave
Chronic Kidney Disease in Patients With Heart Failure With a Preserved Ejection Fraction
errJACC
IF0
err2025-10-15
err0
errOAAI
errMilton Packer; Jeffrey Testani; Javed Butler; Faiez Zannad; Carolyn S.P. Lam; Muthiah Vaduganathan; James C. Fang; Barry A. Borlaug
errShare
errSave
Is Type 2 Diabetes a Modifiable Risk Factor for the Evolution and Progression of Heart Failure With a Preserved Ejection Fraction?
errJACC
IF0
err2025-09-17
err0
errOAAI
errMilton Packer; Carolyn S.P. Lam; Javed Butler; Faiez Zannad; Muthiah Vaduganathan; Barry A. Borlaug
errShare
errSave
Influence of Type 2 Diabetes on the Effects of Tirzepatide in Patients With Heart Failure and a Preserved Ejection Fraction With Obesity
errJACC
IF0
err2025-09-01
err0
errOAAI
errMilton Packer; Michael R. Zile; Christopher M. Kramer; Joseph M. DiMaria; Seth J. Baum; Sheldon E. Litwin; Masahiro Murakami; Chunmei Zhou; Yang Ou; Lisette Koeneman; Barry A. Borlaug
errShare
errSave
Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF
err2025-09-01
err0
errOAAI
errYang, Mingming; Henderson, Alasdair D.; Anand, Inder S.; Desai, Akshay S.; Lam, Carolyn S. P.; Maggioni, Aldo P.; Martinez, Felipe A.; Rouleau, Jean L.; Swedberg, Karl; Vaduganathan, Muthiah; van Veldhuisen, Dirk J.; Zannad, Faiez; Zile, Michael R.; Packer, Milton; Rizkala, Adel; Lewis, Eldrin F.; Jhund, Pardeep S.; Solomon, Scott D.; Mcmurray, John J., V
errShare
errSave
Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
errJACC
IF0
err2025-08-27
err0
PREAI
errJohn W. Ostrominski; Brendon L. Neuen; Brian L. Claggett; Inder S. Anand; Akshay S. Desai; Pardeep S. Jhund; Carolyn S.P. Lam; Marc A. Pfeffer; Bertram Pitt; Faiez Zannad; Michael R. Zile; Milton Packer; Kieran F. Docherty; John J.V. McMurray; Scott D. Solomon; Muthiah Vaduganathan
errShare
errSave
HFpEF-ABA score is a more useful enrichment tool than natriuretic peptides in heart failure with preserved ejection fraction
err2025-08-01
err2
errOAAI
errBorlaug, Barry A.; Zile, Michael R.; Kramer, Christopher M.; Litwin, Sheldon E.; Ye, Wenyu; Ou, Yang; Hurt, Karla; Murakami, Masahiro; Packer, Milton
errShare
errSave
Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF
err2025-07-21
err0
PREAI
errBarry A. Borlaug; Michael R. Zile; Christopher M. Kramer; Wenyu Ye; Yang Ou; Karla Hurt; Masahiro Murakami; Milton Packer
errShare
errSave